Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bruce G Pollock

Showing results (121-130 of 327) with videos related to

Pageof 33
Sort By:
Neurocase|April 21, 2012
A case of apathy due to frontotemporal dementia responsive to memantineKira A Links, Sandra E Black, Ariel Graff-Guerrero, et al.
The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry|November 3, 2012
Therapeutic Window for Striatal Dopamine D2/3 Receptor Occupancy in Older Patients With Schizophrenia: A Pilot PET StudyHiroyuki Uchida, Takefumi Suzuki, Ariel Graff-Guerrero, et al.
Journal of the American Geriatrics Society|September 5, 2007
Maintenance treatment for old-age depression preserves health-related quality of life: a randomized, controlled trial of paroxetine and interpersonal psychotherapyAlexandre Y Dombrovski, Eric J Lenze, Mary Amanda Dew, et al.
Journal of Cardiovascular Electrophysiology|April 29, 2006
Decreasing pain and anxiety associated with patient-activated atrial shock: a placebo-controlled study of adjunctive sedation with oral triazolamTanya J Fabian, David S Schwartzman, Michael R Ujhelyi, et al.
Journal of Clinical Psychopharmacology|November 14, 2009
D2 receptor blockade by risperidone correlates with attention deficits in late-life schizophreniaHiroyuki Uchida, Tarek K Rajji, Benoit H Mulsant, et al.
Journal of Clinical Pharmacology|February 26, 2013
Population pharmacokinetic modeling of sertraline treatment in patients with Alzheimer disease: the DIADS-2 studyClaire H Li, Bruce G Pollock, Constantine G Lyketsos, et al.
Journal of Clinical Psychopharmacology|August 1, 2013
Estimated dopamine D₂ receptor occupancy and remission in schizophrenia: analysis of the CATIE dataSho Moriguchi, Robert R Bies, Gary Remington, et al.
Journal of Psychiatric Research|July 5, 2003
Persistence of cognitive impairment in geriatric patients following antidepressant treatment: a randomized, double-blind clinical trial with nortriptyline and paroxetineRobert D Nebes, Bruce G Pollock, Patricia R Houck, et al.
International Journal of Geriatric Psychiatry|February 26, 2011
Effects of aging on 5-HT(2A) R binding: a HRRT PET study with and without partial volume correctionsHiroyuki Uchida, Tiffany W Chow, David C Mamo, et al.
Journal of Clinical Psychopharmacology|November 25, 2010
Association of 9-hydroxy risperidone concentrations with risk of switching or discontinuation in the clinical antipsychotic trial of intervention effectiveness-Alzheimer's disease trialAlette M Wessels, Bruce G Pollock, Norbert G Anyama, et al.
Pageof 33

Showing results (121-130 of 327) with videos related to

Sort By:
Pageof 33
Neurocase|April 21, 2012
A case of apathy due to frontotemporal dementia responsive to memantineKira A Links, Sandra E Black, Ariel Graff-Guerrero, et al.
The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry|November 3, 2012
Therapeutic Window for Striatal Dopamine D2/3 Receptor Occupancy in Older Patients With Schizophrenia: A Pilot PET StudyHiroyuki Uchida, Takefumi Suzuki, Ariel Graff-Guerrero, et al.
Journal of the American Geriatrics Society|September 5, 2007
Maintenance treatment for old-age depression preserves health-related quality of life: a randomized, controlled trial of paroxetine and interpersonal psychotherapyAlexandre Y Dombrovski, Eric J Lenze, Mary Amanda Dew, et al.
Journal of Cardiovascular Electrophysiology|April 29, 2006
Decreasing pain and anxiety associated with patient-activated atrial shock: a placebo-controlled study of adjunctive sedation with oral triazolamTanya J Fabian, David S Schwartzman, Michael R Ujhelyi, et al.
Journal of Clinical Psychopharmacology|November 14, 2009
D2 receptor blockade by risperidone correlates with attention deficits in late-life schizophreniaHiroyuki Uchida, Tarek K Rajji, Benoit H Mulsant, et al.
Journal of Clinical Pharmacology|February 26, 2013
Population pharmacokinetic modeling of sertraline treatment in patients with Alzheimer disease: the DIADS-2 studyClaire H Li, Bruce G Pollock, Constantine G Lyketsos, et al.
Journal of Clinical Psychopharmacology|August 1, 2013
Estimated dopamine D₂ receptor occupancy and remission in schizophrenia: analysis of the CATIE dataSho Moriguchi, Robert R Bies, Gary Remington, et al.
Journal of Psychiatric Research|July 5, 2003
Persistence of cognitive impairment in geriatric patients following antidepressant treatment: a randomized, double-blind clinical trial with nortriptyline and paroxetineRobert D Nebes, Bruce G Pollock, Patricia R Houck, et al.
International Journal of Geriatric Psychiatry|February 26, 2011
Effects of aging on 5-HT(2A) R binding: a HRRT PET study with and without partial volume correctionsHiroyuki Uchida, Tiffany W Chow, David C Mamo, et al.
Journal of Clinical Psychopharmacology|November 25, 2010
Association of 9-hydroxy risperidone concentrations with risk of switching or discontinuation in the clinical antipsychotic trial of intervention effectiveness-Alzheimer's disease trialAlette M Wessels, Bruce G Pollock, Norbert G Anyama, et al.
Pageof 33